Potential epigenetic molecular regulatory networks in ocular neovascularization

Area of Science:

• Ophthalmology
• Molecular Biology
• Genetics

Background:

• Ocular neovascularization, seen in corneal injury and retinal/choroidal vascular diseases, is a significant cause of vision loss.
• Current anti-VEGF treatments for neovascularization have limitations, including potential neurological and developmental side effects with long-term use.
• There is a critical need for novel therapeutic strategies to manage ocular neovascularization effectively and safely.

Purpose of the Study:

• To review recent advancements in understanding the epigenetic regulation of ocular neovascularization.
• To highlight novel epigenetic mechanisms involved in ocular neovascularization.
• To discuss the potential of epigenetic therapeutics for treating ocular neovascularization.

Main Methods:

• Literature review of recent studies on epigenetic mechanisms in ocular neovascularization.
• Analysis of DNA methylation, histone modification, non-coding RNA, and mRNA modification roles.
• Synthesis of findings on epigenetic control pathways in ocular diseases.

Main Results:

• Epigenetic regulation plays a crucial role in the development of ocular neovascularization.
• Specific epigenetic mechanisms, including DNA methylation and non-coding RNAs, are implicated in ocular vascular diseases.
• Emerging evidence suggests these epigenetic pathways are druggable targets.

Conclusions:

• Epigenetic mechanisms are key regulators of ocular neovascularization.
• Targeting epigenetic modifications offers a promising avenue for developing new treatments for ocular neovascularization.
• Further research into epigenetic therapeutics could lead to safer and more effective interventions for vision-threatening ocular conditions.